Veeva Systems
VEEV
$275.09
-3.27%
Veeva Systems Inc. is a leading provider of cloud-based software solutions specifically designed for the life sciences industry, offering products like Veeva CRM for sales and marketing and Veeva Vault for content and data management. As a dominant player in this niche, Veeva has established a strong competitive moat by addressing the unique regulatory and operational needs of pharmaceutical and biotech companies, displacing legacy systems. The current investor narrative centers on the company's accelerating growth driven by Vault CRM adoption and AI momentum, as highlighted by its recent Q2 earnings beat and raised FY27 outlook, which has fueled a sharp stock rally. However, debates persist regarding the sustainability of its growth premium and the potential impact of regulatory changes in the life sciences sector.…
VEEV
Veeva Systems
$275.09
Related headlines
VEEV 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Veeva Systems's 12-month outlook, with a consensus price target around $295.18 and implied upside of +7.3% versus the current price.
Average Target
$295.18
0 analysts
Implied Upside
+7.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$180 - $350
Analyst target range
The target price range spans from a low of $180.00 to a high of $350.00, indicating a wide dispersion of expectations. The low target suggests a potential downside of 34.6% from the current price, likely reflecting concerns about valuation or competitive pressures, while the high target implies a 27.2% upside, assuming continued strong growth and multiple expansion. The wide spread between the low and high targets highlights significant uncertainty about Veeva's future performance, but the overall bullish consensus and recent upward guidance revisions suggest that analysts are increasingly confident in the company's growth trajectory.
VEEV Technical Analysis
Veeva's stock has exhibited a robust recovery from its April 2026 lows, with the current price of $275.09 representing a significant rebound from the 52-week low of $148.05. Over the past year, the stock is up 1.86%, but this masks a dramatic intra-year swing; the price is currently trading at 88.6% of its 52-week range (between $148.05 and $310.50), indicating a strong recovery from the lows but still below the highs. The stock's 6-month change of +40.72% and YTD change of +25.33% underscore a powerful uptrend, though the 1-year change is modest, suggesting the recovery is recent and has yet to fully offset earlier declines.
Beta
0.97
0.97x market volatility
Max Drawdown
-50.5%
Largest decline past year
52-Week Range
$148-$311
Price range past year
Annual Return
+1.9%
Cumulative gain past year
| Period | VEEV Return | S&P 500 |
|---|---|---|
| 1m | +28.8% | -0.4% |
| 3m | +59.4% | +4.2% |
| 6m | +40.7% | +13.7% |
| 1y | +1.9% | +19.0% |
| ytd | +25.3% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
VEEV Fundamental Analysis
Veeva's revenue growth has been accelerating, with the most recent quarter (Q1 FY2027, ending April 30, 2026) reporting revenue of $882.9 million, a 16.3% YoY increase, up from the prior quarter's 15.3% growth. This marks a steady acceleration from the 8.9% growth in Q2 FY2026 and reflects strong demand for its Vault and CRM solutions. The company's subscription revenue, which forms the bulk of total revenue, continues to drive growth, with professional services adding incremental revenue. The raised FY27 guidance, as noted in recent news, suggests management expects this momentum to persist, reinforcing the positive growth narrative.
Quarterly Revenue
$882948000.0B
2026-04
Revenue YoY Growth
+16.3%
YoY Comparison
Gross Margin
74.7%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is VEEV Overvalued?
Given Veeva's positive net income, the PE ratio is the primary valuation metric. The trailing PE stands at 36.74x, while the forward PE is 26.86x, indicating that the market expects significant earnings growth. The gap between trailing and forward PE implies an anticipated earnings increase of approximately 37% over the next year, reflecting optimism about the company's growth prospects. This is consistent with the PEG ratio of 1.42, which suggests the stock is reasonably priced relative to its expected growth rate.
PE
36.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 24x~97x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
25.7x
Enterprise Value Multiple

